CXCL12 and neoplasm: Studies on mouse models of PDAC have shown that the population of CAFs expressing SMA exhibit increased Shh signaling, which inhibit the production of VEGF, CXCL12, and IL-8, factors that promote angiogenesis, tumor growth, and immunosuppression in the TME.